Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL

NCT02603445

Conditions
Follicular Lymphoma, Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Novartis Investigative Site New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Salzburg, Austria
  • Novartis Investigative Site Pierre-Bénite, France
View Trial Details
Completed

A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT01691898

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver, Colorado, United States
  • Georgetown University Medical Center Lombardi Cancer Center Washington D.C., District of Columbia, United States
View all 41 locations
View Trial Details
Completed

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

NCT01836484

Conditions
Cervical Cancer: Invasive Disease, FIGO Stage 1B1 or Higher, Disease, Endometrial Cancer, +29 more
Locations
  • Queen Elizabeth Hospital, Birmingham University Hospitals, Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham City Hospital, Sandwell & West Birmingham Hospitals NHS Trust Birmingham, United Kingdom
  • St Bartholomew's Hospital, Barts Health NHS Trust London, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Completed

A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

NCT00426764

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moore UCSD Cancer Center La Jolla, California, United States
  • UCLA Division of Hematology Oncology Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
View all 90 locations
View Trial Details
Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01207388

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • 1102 - LKH Graz Graz, Austria
  • 1107 - Krankenhaus der Elisabethinen Linz, Austria
  • 1106 Salzburg, Austria
  • 1101 - AKH Wien Vienna, Austria
View all 75 locations
View Trial Details
Completed

A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

NCT02377947

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +18 more
Locations
  • Medanta Hospital Gurgaon, India
  • Research facility ORG-000333 Gurgaon, India
  • Sir Ganga Ram Hospital New Delhi, India
View Trial Details

Related conditions